Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A19309 | 26636404 | Eur J Gastroenterol Hepatol | Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men. | 2016 | Details |
A19310 | 26635079 | BMC Gastroenterol | Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol. | 2015 | Details |
A19319 | 26631018 | Lipids Health Dis | Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis. | 2015 | Details |
A19323 | 26629547 | EBioMedicine | Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals. | 2015 | Details |
A19328 | 26628836 | J Clin Exp Hepatol | Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice. | 2015 | Details |
A19329 | 26627127 | Comp Biochem Physiol B Biochem Mol Biol | Expression of mitochondria-related genes is elevated in overfeeding-induced goose fatty liver. | 2015 | Details |
A19332 | 26626496 | J Hepatol | Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver disease. | 2015 | Details |
A19340 | 26620317 | Sci Rep | Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease. | 2015 | Details |
A19342 | 26620035 | Mymensingh Med J | Non-alcoholic Fatty Liver Disease (NAFLD)--A Review. | 2015 | Details |
A19343 | 26619823 | Sci Rep | Absence of Elovl6 attenuates steatohepatitis but promotes gallstone formation in a lithogenic diet-fed Ldlr(-/-) mouse model. | 2015 | Details |
A19344 | 26619117 | J Clin Invest | E2F1 mediates sustained lipogenesis and contributes to hepatic steatosis. | 2015 | Details |
A19345 | 26618774 | PLoS One | A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study. | 2015 | Details |
A19351 | 26613006 | Diabetol Metab Syndr | The association of circulating levels of complement-C1q TNF-related protein 5 (CTRP5) with nonalcoholic fatty liver disease and type 2 diabetes: a case-control study. | 2015 | Details |
A19352 | 26612838 | Toxicol Sci | Polychlorinated Biphenyl-Xenobiotic Nuclear Receptor Interactions Regulate Energy Metabolism, Behavior, and Inflammation in Non-alcoholic-Steatohepatitis. | 2015 | Details |
A19360 | 26608256 | Lancet | Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. | 2015 | Details |
A19363 | 26603489 | Sci Rep | Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E. | 2015 | Details |
A19377 | 26599819 | PLoS One | Lipoprotein Profiles in Class III Obese Caucasian and African American Women with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
A19378 | 26599575 | PLoS One | Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features. | 2015 | Details |
A19379 | 26599361 | PLoS One | Phenotype, Body Composition, and Prediction Equations (Indian Fatty Liver Index) for Non-Alcoholic Fatty Liver Disease in Non-Diabetic Asian Indians: A Case-Control Study. | 2015 | Details |
A19384 | 26597657 | Obes Rev | Association of recently described adipokines with liver histology in biopsy-proven non-alcoholic fatty liver disease: a systematic review. | 2015 | Details |
A19385 | 26597602 | J Diabetes Complications | Chronic fructose intake accelerates non-alcoholic fatty liver disease in the presence of essential hypertension. | 2015 | Details |
A19388 | 26594248 | Diabetol Metab Syndr | Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus. | 2015 | Details |
A19389 | 26594198 | Front Endocrinol (Lausanne) | Sexual Dimorphism of Adipose and Hepatic Aquaglyceroporins in Health and Metabolic Disorders. | 2015 | Details |
A19390 | 26593707 | Eur J Pharmacol | Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats. | 2015 | Details |
A19398 | 26592314 | Proc Nutr Soc | Polyphenols and non-alcoholic fatty liver disease: impact and mechanisms. | 2015 | Details |
A19402 | 26589977 | J Gastroenterol Hepatol | Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys. | 2016 | Details |
A19405 | 26587039 | Hepat Mon | Effect of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease. | 2015 | Details |
A19408 | 26586275 | Prog Cardiovasc Dis | The Evidence for Saturated Fat and for Sugar Related to Coronary Heart Disease. | 2015 | Details |
A19416 | 26580981 | ACS Chem Biol | Interrogating Endogenous Protein Phosphatase Activity with Rationally Designed Chemosensors. | 2015 | Details |
A19417 | 26580662 | J Clin Med | MicroRNA Expression Relating to Dietary-Induced Liver Steatosis and NASH. | 2015 | Details |
A19418 | 26580649 | Nutrients | The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis. | 2015 | Details |
A19424 | 26576055 | PLoS One | Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls. | 2015 | Details |
A19426 | 26573193 | Zhonghua Gan Zang Bing Za Zhi | [Relationship of socioeconomic status and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus]. | 2015 | Details |
A19431 | 26571396 | J Clin Invest | Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver. | 2015 | Details |
A19436 | 26569494 | PLoS One | Gender Specific Association of Serum Leptin and Insulinemic Indices with Nonalcoholic Fatty Liver Disease in Prediabetic Subjects. | 2015 | Details |
A19446 | 26566287 | PLoS One | Non-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus. | 2015 | Details |
A19459 | 26557952 | World J Hepatol | Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the future. | 2015 | Details |
A19461 | 26556986 | World J Gastroenterol | Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico. | 2015 | Details |
A19462 | 26556368 | Nutrients | Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance. | 2015 | Details |
A19469 | 26547273 | Med Hypotheses | Involvement of steatosis-induced glucagon resistance in hyperglucagonaemia. | 2015 | Details |
A19472 | 26540639 | Ren Fail | Increased microalbuminuria prevalence among patients with nonalcoholic fatty liver disease. | 2015 | Details |
A19485 | 26528424 | J Lifestyle Med | Comorbidities and Metabolic Derangement of NAFLD. | 2015 | Details |
A19488 | 26525342 | Physiology (Bethesda) | Integration of ChREBP-Mediated Glucose Sensing into Whole Body Metabolism. | 2015 | Details |
A19494 | 26523207 | World J Hepatol | Role of pentoxifylline in non-alcoholic fatty liver disease in high-fat diet-induced obesity in mice. | 2015 | Details |
A19495 | 26523205 | World J Hepatol | Dietary approach in the treatment of nonalcoholic fatty liver disease. | 2015 | Details |
A19500 | 26518991 | Transl Res | Diet-induced dyslipidemia leads to nonalcoholic fatty liver disease and oxidative stress in guinea pigs. | 2015 | Details |
A19503 | 26517932 | Biochem Soc Trans | The TRIB3 Q84R polymorphism, insulin resistance and related metabolic alterations. | 2015 | Details |
A19521 | 26512643 | Int J Mol Sci | Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
A19536 | 26503843 | Liver Int | The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial. | 2015 | Details |
A19538 | 26502288 | Gynecol Endocrinol | Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS. | 2015 | Details |
A19544 | 26498267 | Environ Toxicol Pharmacol | Fucoidan ameliorates steatohepatitis and insulin resistance by suppressing oxidative stress and inflammatory cytokines in experimental non-alcoholic fatty liver disease. | 2015 | Details |
A19545 | 26496770 | Acta Diabetol | Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components. | 2015 | Details |
A19548 | 26494962 | World J Gastroenterol | Endocrine causes of nonalcoholic fatty liver disease. | 2015 | Details |
A19551 | 26494024 | Nutr Res Rev | Murine models provide insight to the development of non-alcoholic fatty liver disease. | 2015 | Details |
A19558 | 26486292 | Arq Gastroenterol | INFLUENCE OF OXIDATIVE STRESS AND OBESITY IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS. | 2016 | Details |
A19560 | 26485614 | Endocrinology | The PGE2 EP3 Receptor Regulates Diet-Induced Adiposity in Male Mice. | 2015 | Details |
A19562 | 26485433 | PLoS One | 3,5 Diiodo-L-Thyronine (T2) Does Not Prevent Hepatic Steatosis or Insulin Resistance in Fat-Fed Sprague Dawley Rats. | 2015 | Details |
A19565 | 26482965 | Diabetes Metab Syndr | Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD. | 2015 | Details |
A19572 | 26476631 | Eur J Nutr | A possible link between hepatic mitochondrial dysfunction and diet-induced insulin resistance. | 2016 | Details |
A19573 | 28962484 | Toxicol Rep | Effects of 4-nonylphenol on oxidant/antioxidant balance system inducing hepatic steatosis in male rat. | 2015 | Details |
A19581 | 26473614 | Hepatology | Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease. | 2015 | Details |
A19585 | 26473136 | Pediatr Gastroenterol Hepatol Nutr | Low Serum Potassium Levels Associated with Disease Severity in Children with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
A19589 | 26471014 | Food Funct | Anti-steatotic effects of an n-3 LCPUFA and extra virgin olive oil mixture in the liver of mice subjected to high-fat diet. | 2016 | Details |
A19592 | 26468154 | Curr Diab Rep | Epidemiology of NAFLD and Type 2 Diabetes: Health Disparities Among Persons of Hispanic Origin. | 2015 | Details |
A19594 | 26464753 | World J Hepatol | Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathways. | 2015 | Details |
A19601 | 26462866 | Diabetes Obes Metab | Retinoic acid receptor β2 agonists restore glycaemic control in diabetes and reduce steatosis. | 2015 | Details |
A19607 | 26461295 | Free Radic Biol Med | The effect of Irisin on antioxidant system in liver. | 2014 | Details |
A19610 | 26458397 | BMC Med Genet | MTTP-297H polymorphism reduced serum cholesterol but increased risk of non-alcoholic fatty liver disease-a cross-sectional study. | 2015 | Details |
A19622 | 26450277 | Br J Nutr | Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH). | 2015 | Details |
A19635 | 26445592 | Nutr Metab (Lond) | Quercetin reduces obesity-induced hepatosteatosis by enhancing mitochondrial oxidative metabolism via heme oxygenase-1. | 2015 | Details |
A19636 | 26444696 | Liver Int | Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study. | 2015 | Details |
A19637 | 26444605 | Clin Hemorheol Microcirc | Association of whole blood viscosity with non-alcoholic fatty liver disease. | 2015 | Details |
A19638 | 26444279 | Clin Exp Pharmacol Physiol | Increased ratio of neutrophil elastase to α1-antitrypsin is closely associated with liver inflammation in patients with nonalcoholic steatohepatitis. | 2016 | Details |
A19641 | 26441837 | Front Endocrinol (Lausanne) | Research Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLD. | 2015 | Details |
A19645 | 26439744 | PLoS One | Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
A19646 | 26439042 | Eur Rev Med Pharmacol Sci | Insulin sensitivity indices: fasting versus glucose-stimulated ındices in pediatric non-alcoholic fatty liver disease. | 2015 | Details |
A19648 | 26438057 | Biometals | Core domain mutant Y220C of p53 protein has a key role in copper homeostasis in case of free fatty acids overload. | 2015 | Details |
A19649 | 26438035 | BMC Complement Altern Med | Extracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivity. | 2015 | Details |
A19654 | 26435078 | Metabolism | The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome. | 2015 | Details |
A19657 | 26433072 | Mol Cell Endocrinol | Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction. | 2015 | Details |
A19658 | 26432021 | Trends Mol Med | Emerging Liver-Kidney Interactions in Nonalcoholic Fatty Liver Disease. | 2015 | Details |
A19660 | 26430826 | J Am Coll Nutr | Effects of Multistrain Probiotic Supplementation on Glycemic and Inflammatory Indices in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial. | 2015 | Details |
A19669 | 26425466 | Indian J Endocrinol Metab | Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes. | 2015 | Details |
A19670 | 26424731 | Clin Sci (Lond) | Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease. | 2015 | Details |
A19671 | 26423681 | Biochem Genet | Effects of Fatty Acids on CYP2A5 and Nrf2 Expression in Mouse Primary Hepatocytes. | 2015 | Details |
A19672 | 26423094 | J Endocrinol | Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis. | 2015 | Details |
A19673 | 26420354 | Eur J Pharmacol | Deficiency in apolipoprotein A-I ablates the pharmacological effects of metformin on plasma glucose homeostasis and hepatic lipid deposition. | 2015 | Details |
A19674 | 26420011 | Environ Health | Persistent organic pollutants and non-alcoholic fatty liver disease in morbidly obese patients: a cohort study. | 2015 | Details |
A19676 | 26419119 | Expert Opin Ther Targets | Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease. | 2015 | Details |
A19678 | 28294798 | Kardiologiia | [Safety and Efficacy of Amlodipine, Lisinopril and Rosuvastatin Therapy in Patients With Metabolic Syndrome and Nonalcoholic Fatty Liver Disease]. | 2015 | Details |
A19681 | 26416722 | Arch Biochem Biophys | MicroRNAs in obesity-associated disorders. | 2015 | Details |
A19684 | 26412465 | Curr Pharm Des | Nonalcoholic fatty liver disease in children and adolescents - Relationship with Polycystic Ovary Syndrome. | 2015 | Details |
A19685 | 26411937 | Nihon Eiseigaku Zasshi | [Mechanism Analysis and Prevention of Pathogenesis of Nonalcoholic Steatohepatitis]. | 2015 | Details |
A19689 | 26408952 | Prostaglandins Other Lipid Mediat | Metabolites of arachidonic acid and linoleic acid in early stages of non-alcoholic fatty liver disease--A pilot study. | 2015 | Details |
A19690 | 26408054 | Contemp Clin Trials | The effect of a multidisciplinary intervention program on hepatic adiposity in overweight-obese children: protocol of the EFIGRO study. | 2015 | Details |
A19691 | 26407715 | Diabetologia | Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis. | 2015 | Details |
A19692 | 26407654 | Eur J Pharmacol | Perindopril and barnidipine alone or combined with simvastatin on hepatic steatosis and inflammatory parameters in hypertensive patients. | 2015 | Details |
A19693 | 26406351 | J Dig Dis | Nonalcoholic fatty liver disease - current status and future directions. | 2015 | Details |
A19698 | 26405708 | J Gastrointestin Liver Dis | Hype or Reality: Should Patients with Metabolic Syndrome-related NAFLD be on the Hunter-Gatherer (Paleo) Diet to Decrease Morbidity? | 2015 | Details |
A19699 | 26405701 | J Gastrointestin Liver Dis | The Relationship of Serum Hemojuvelin and Hepcidin Levels with Iron Overload in Nonalcoholic Fatty Liver Disease. | 2015 | Details |